Black Diamond Therapeutics (BDTX) EV/EBITDA US GAAP (year values)

2019 2020 2021 2022 2023   LTM ?
EV/EBITDA ? -1.57 -11.2 -0.09 0.32 -0.20   -0.11
Changes by years, y/y, % -127% +616% -99% -447% -164%    

Black Diamond Therapeutics. EV/EBITDA

Black Diamond Therapeutics. EV/EBITDA, changes, %

Black Diamond Therapeutics (BDTX) EV/EBITDA US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
EV/EBITDA ? -0.31 -0.45 -2.03 -1.81 -1.95   -0.11
Changes by years, y/y, % -83% -247% -2 742% +31% +523%    
Changes by quarters, q/q, % -78% +45% +348% -10% +7%    

Black Diamond Therapeutics. EV/EBITDA

Black Diamond Therapeutics. EV/EBITDA, changes, y/y, %

Black Diamond Therapeutics. EV/EBITDA, changes, q/q, %